Associate Professor of Surgery, Brigham and Women's Hospital
General Surgery
Dr. Edward E. Whang, MD
|
|
Give Review
Dr. Edward E. Whang practices General Surgery. He researched medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care He has 1 awards "Fellow (FACS)". Dr. Edward E. Whang is a published doctor. He has 81 publications published. The most current publication "The Impact of Overestimations of Surgical Control Times Across Multiple Specialties on Medical Systems." He is registered with Medicare.
Publications
- Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
- Radiation therapy for unresectable pancreatic adenoCarcinoma: population-based trends in utilization and survival rates in the United States.
- Population-Based Outcome of Stage IA-IIA Resected Gastric AdenoCarcinoma: Who Should Get Adjuvant Treatment?
- Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive Cancers.
- Tumor Size and Depth Predict Rate of Lymph Node Metastasis in Colon Carcinoids and Can Be Used to Select Patients for Endoscopic Resection.
- Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-...
- Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical Cancers.
- Appendectomy in pregnancy: evaluation of the risks of a negative appendectomy.
- Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid Cancer.
- Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid Cancer.
- Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid Cancer cells with the BRAFV600E mutation.
- Surgery and staging of Pancreatic neuroendocrine tumors: a 14-year experience.
- Autophagy: a new target for advanced papillary thyroid Cancer therapy.
- Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid Cancer.
- Impact of radiologic intervention on mortality in necrotizing pancreatitis: the role of organ failure.
- Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid Cancer cells.
- Surgical resection versus palliative chemoradiotherapy for the management of pancreatic cancer with local venous invasion: a decision Analysis.
- Timing of cholecystectomy for Biliary pancreatitis: do the data support current guidelines?
- Distal pancreatectomy is not associated with increased perioperative morbidity when performed as part of a multivisceral resection.
- Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary Cancer care.
- Is ductal evaluation always necessary before or during surgery for Biliary pancreatitis?
- Pancreatic pseudocysts: is delayed surgical intervention associated with adverse outcomes?
- RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
- The molecular biology of pancreatic Cancer.
- HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenoCarcinoma.
- Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenoCarcinoma.
- Differential role of vagus nerve in maintaining diurnal gene expression rhythms in the proximal small intestine.
- Brachial plexus injury from CT-guided RF ablation under general anesthesia.
- Risk factors and outcomes of pancreatitis after open heart surgery.
- The future of surgery: today's residents speak.
- Surgical residents' perceptions of the effects of the ACGME duty hour requirements 1 year after implementation.
- RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells.
- Epigenetics and biliary Cancer: promise and pitfalls.
- RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenoCarcinoma cell gemcitabine chemoresistance.
- CEACAM6 is a novel biomarker in pancreatic adenoCarcinoma and PanIN lesions.
- Glucagon-like peptide 2 is an endogenous mediator of postresection Intestinal adaptation.
- Impact of menopausal status on the behavior of Pancreatic cystic neoplasms in women.
- AdenoCarcinoma of the gastric cardia: what is the optimal surgical approach?
- Effect of glucagon-like peptide-2 (GLP-2) on diurnal SGLT1 expression.
- Prostaglandin E2 enhances pancreatic Cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.
- Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of Cancer.
- Glucagon-like peptide-2: divergent signaling pathways.
- Glucose transporter-1 gene expression is associated with pancreatic Cancer invasiveness and MMP-2 activity.
- Maternal and fetal deaths after gastric bypass surgery for morbid obesity.
- Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenoCarcinoma cellular invasiveness.
- Intestinal tissue engineering: from regenerative medicine to model systems.
- Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic Cancer.
- A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenoCarcinoma cells.
- siRNA directed against c-Src enhances pancreatic adenoCarcinoma cell gemcitabine chemosensitivity.
- CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenoCarcinoma cells.
- Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.
- CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenoCarcinoma.
- Lymphangiogenesis in tissue-engineered small intestine.
- c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenoCarcinoma cell adhesion to extracellular matrix components.
- Appendiceal adenoCarcinoma: long-term outcomes after surgical therapy.
- RNA interference: a practical approach.
- Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenoCarcinoma cells.
- Treatment outcomes associated with surgery for gallbladder Cancer: a 20-year experience.
- Inhibition of pancreatic adenoCarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor.
- Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine.
- Angiogenesis in tissue-engineered small intestine.
- The efficacy of tyrosine kinase inhibitors on human pancreatic Cancer cell lines.
- RNA interference targeting focal adhesion kinase enhances pancreatic adenoCarcinoma gemcitabine chemosensitivity.
- Surgical treatment of small bowel Cancer: a 20-year single institution experience.
- Work hours reform: perceptions and desires of contemporary surgical residents.
- Ghrelin promotes pancreatic adenoCarcinoma cellular proliferation and invasiveness.
- Autoantibody-mediated inhibition of pancreatic Cancer cell growth in an athymic (nude) mouse model.
- Inhibition of tyrosine kinase Src suppresses pancreatic Cancer invasiveness.
- Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture.
- Benign nonampullary duodenal neoplasms.
- Implementing resident work hour limitations: lessons from the New York State experience.
- Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography.
- Luminal nutrient signals for Intestinal adaptation in pythons.
- Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis?
- Tissue-engineered small intestine: ontogeny of the immune system.
- Glucagon-like peptide 2 enhances Intestinal epithelial restitution.
- Understanding and augmenting human Intestinal adaptation: a call for more clinical research.
- Glucagon-like peptide 2 stimulates Intestinal epithelial proliferation in vitro.
- Differential display of expressed genes in pancreatic Cancer cells.
- The Impact of Overestimations of Surgical Control Times Across Multiple Specialties on Medical Systems.
Schools
University Of ChicagoThe Pritzker School Of Medicine
UCLA Med Center
Procedures Preformed
- Colectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Gallbladder Removal (Cholecystectomy), Laparoscopic
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Anal Fissure
- Appendicitis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
UCLA Medical Center -
University of Chicago Pritzker School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790741452 |
| Last Name Of The Provider | WHANG |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
|
Dr. Abraham M. Liberman, MD |
|
|
Dr. George Molina, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Satish R. Javali, MB BS |
|
|
Abby White |
|
|
Dr. Daniel A. Hashimoto, MD |
|
|
Dr. Brian C. George, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roland A. Hernandez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omair Shakil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lorenzo E. Anez Bustillos, MD |
|
|
Dr. Grace A. Nicksa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vihas Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall D. Gaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica E. Young, MD |
|
|
Dr. Alan C. Sherburne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gustavo Bauza, MD
This Doctor is OpenDoctor Recommended.
|